For Healthcare Professionals Only.
Journal: Journal of Cancer Research and Clinical Oncology
Validity Period (for CME): March 2026
(click to expand) Information for Doctor CME Category 3A (Self-study)
CME points will be awarded to doctors who submit claims for reading papers from Refereed Journals recommended by SMC or listed in PubMed. Papers must be published within the last 2 years. Claims from other publications, such as newsletters, magazines or non-refereed journals, will be rejected. This article serves as a concise overview of the key insights extracted from the original article. Hence, ensure to cite the actual research paper in your CME Cat. 3A claim. Link to the paper is provided in the footnotes. For more information, visit: [Criteria], [List]
(click to expand) Information for Pharmacist CPE Category 3A (Reading)
CPE points will be award to pharmacists who submit claims for reading papers from the list of journals recommended by the SPC if they wish to minimise the rejection of claims for reading non-recognised materials. This article serves as a concise overview of the key insights extracted from the original article. Hence, ensure to cite the actual research paper in your CPE Cat. 3A claim. Link to the paper is provided in the footnotes. For more information, visit: [Main], [Guide, Page 26], [List]
Skin Carcinomas and Cutaneous Squamous Cell Carcinoma (cSCC)
- Skin carcinomas rank as the most prevalent human cancers, with cSCC being the second most common type following basal cell carcinoma.
- Solar ultraviolet radiation and immunosuppression are primary risk factors for cSCC, contributing significantly to its incidence.
- Incidence rates of cSCC have been steadily rising among white-skinned populations, indicating a growing public health concern.
Login to read more
